Safety and Immune Response to a Mammaglobin-A DNA Vaccine In Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy

Clinical trial NCT02204098 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02204098
Sponsor: Washington University School of Medicine
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Cancer Breast Carcinoma Malignant Neoplasm of Breast

Start date: 2015-01-07
Primary completion: 2022-04-06
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.